Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMC 114017)

Published in J Virol on February 01, 2001

Authors

E C Coronel1, T Takimoto, K G Murti, N Varich, A Portner

Author Affiliations

1: Department of Virology and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

Articles citing this

Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles. J Virol (2004) 2.92

Parainfluenza viruses. Clin Microbiol Rev (2003) 2.39

Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol (2010) 1.44

Ebola virus VP35-VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles. J Virol (2006) 1.31

Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. Virol J (2007) 1.30

The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J Virol (2009) 1.24

The intrinsically disordered C-terminal domain of the measles virus nucleoprotein interacts with the C-terminal domain of the phosphoprotein via two distinct sites and remains predominantly unfolded. Protein Sci (2005) 1.20

Association of ebola virus matrix protein VP40 with microtubules. J Virol (2005) 1.18

A catalytically and genetically optimized beta-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics. Virol J (2009) 1.15

Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus. J Virol (2007) 1.14

Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion. J Virol (2007) 1.13

Trafficking of Sendai virus nucleocapsids is mediated by intracellular vesicles. PLoS One (2010) 1.12

A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. J Virol (2010) 1.10

A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading. J Virol (2003) 1.10

Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins. J Virol (2003) 1.06

Biarsenical labeling of vesicular stomatitis virus encoding tetracysteine-tagged m protein allows dynamic imaging of m protein and virus uncoating in infected cells. J Virol (2009) 1.00

Borna disease virus matrix protein is an integral component of the viral ribonucleoprotein complex that does not interfere with polymerase activity. J Virol (2006) 0.92

The C-terminal end of parainfluenza virus 5 NP protein is important for virus-like particle production and M-NP protein interaction. J Virol (2010) 0.90

Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex. J Virol (2014) 0.89

Paramyxovirus glycoprotein incorporation, assembly and budding: a three way dance for infectious particle production. Viruses (2014) 0.89

Peste des petits ruminants virus infection of small ruminants: a comprehensive review. Viruses (2014) 0.85

Evidence for ubiquitin-regulated nuclear and subnuclear trafficking among Paramyxovirinae matrix proteins. PLoS Pathog (2015) 0.85

High-throughput virtual screening and docking studies of matrix protein vp40 of ebola virus. Bioinformation (2013) 0.83

Gene-specific contributions to mumps virus neurovirulence and neuroattenuation. J Virol (2011) 0.83

Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine. J Gen Virol (2007) 0.83

The human metapneumovirus matrix protein stimulates the inflammatory immune response in vitro. PLoS One (2011) 0.83

Critical role of the fusion protein cytoplasmic tail sequence in parainfluenza virus assembly. PLoS One (2013) 0.82

Interaction of Human Parainfluenza Virus Type 3 Nucleoprotein with Matrix Protein Mediates Internal Viral Protein Assembly. J Virol (2015) 0.78

Critical role of Rab11a-mediated recycling endosomes in the assembly of type I parainfluenza viruses. Virology (2015) 0.77

C-Terminal DxD-Containing Sequences within Paramyxovirus Nucleocapsid Proteins Determine Matrix Protein Compatibility and Can Direct Foreign Proteins into Budding Particles. J Virol (2016) 0.76

Mutations in the transmembrane domain and cytoplasmic tail of Hendra virus fusion protein disrupt virus-like particle assembly. J Virol (2017) 0.75

Articles cited by this

Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64

Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene (1989) 23.74

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol (1987) 11.36

The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol (1993) 6.38

Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol (1998) 3.60

Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol (1992) 2.73

Protein-protein interactions within paramyxoviruses identified by native disulfide bonding or reversible chemical cross-linking. J Virol (1980) 2.40

The Sendai virus nucleocapsid exists in at least four different helical states. J Virol (1989) 2.30

Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures. J Virol (1999) 1.93

Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion. Virology (1994) 1.91

Assembly of nucleocapsidlike structures in animal cells infected with a vaccinia virus recombinant encoding the measles virus nucleoprotein. J Virol (1991) 1.73

The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation. J Virol (1993) 1.61

The conserved N-terminal region of Sendai virus nucleocapsid protein NP is required for nucleocapsid assembly. J Virol (1993) 1.55

The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication. J Virol (1998) 1.52

Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions. J Virol (1998) 1.43

Measles virus nucleocapsid protein expressed in insect cells assembles into nucleocapsid-like structures. J Gen Virol (1993) 1.40

Domains of the measles virus N protein required for binding to P protein and self-assembly. Virology (1996) 1.32

A functional antigenomic promoter for the paramyxovirus simian virus 5 requires proper spacing between an essential internal segment and the 3' terminus. J Virol (1998) 1.27

RNA replication for the paramyxovirus simian virus 5 requires an internal repeated (CGNNNN) sequence motif. J Virol (1999) 1.24

Structural and functional analysis of Sendai virus nucleocapsid protein NP with monoclonal antibodies. Virology (1984) 1.21

A highly conserved region of the Sendai virus nucleocapsid protein contributes to the NP-NP binding domain. Virology (1997) 1.19

The carboxy-terminal domain of Sendai virus nucleocapsid protein is involved in complex formation between phosphoprotein and nucleocapsid-like particles. Virology (1994) 1.17

The assembly of the measles virus nucleoprotein into nucleocapsid-like particles is modulated by the phosphoprotein. Virology (1997) 1.15

Localization of P, NP, and M proteins on Sendai virus nucleocapsid using immunogold labeling. Virology (1986) 1.11

Sequence characterization and expression of the matrix protein gene of human parainfluenza virus type 1. Virology (1992) 1.05

Assembly of recombinant Newcastle disease virus nucleocapsid protein into nucleocapsid-like structures is inhibited by the phosphoprotein. J Gen Virol (1997) 1.03

Articles by these authors

Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology (1998) 7.99

Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology (1978) 7.35

A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A (1997) 6.86

Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature (1994) 5.49

The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88. EMBO J (1997) 4.65

Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol (2000) 4.10

Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol (2000) 2.97

Secondary structural features in the 70S RNAs of Moloney murine leukemia and Rous sarcoma viruses as observed by electron microscopy. J Virol (1981) 2.82

The Sendai virus nucleocapsid exists in at least four different helical states. J Virol (1989) 2.30

The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication. J Virol (1996) 2.30

Properties of incomplete Sendai virions and subgenomic viral RNAs. Virology (1970) 2.26

Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J Virol (1996) 2.26

Similar frequencies of antigenic variants in Sendai, vesicular stomatitis, and influenza A viruses. Virology (1980) 2.11

Sendai virus replication: an ultrastructural comparison of productive and abortive infections in avian cells. J Gen Virol (1970) 1.98

Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures. J Virol (1999) 1.93

Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion. Virology (1994) 1.91

Ribonucleic acid transcriptases in Sendai Virions and infected cells. J Virol (1971) 1.84

Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene (1995) 1.78

Genetic apparatus of Stylonychia sp. Nature (1973) 1.72

Chromosome structure in ciliated protozoans. Cold Spring Harb Symp Quant Biol (1974) 1.71

Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus. J Virol (1988) 1.67

Distribution of hemagglutinin and neuraminidase on influenza virions as revealed by immunoelectron microscopy. Virology (1986) 1.64

An 18-amino acid deletion in an influenza neuraminidase. Virology (1985) 1.62

Role of matrix and fusion proteins in budding of Sendai virus. J Virol (2001) 1.58

Assembly of influenza ribonucleoprotein in vitro using recombinant nucleoprotein. Virology (1987) 1.56

In vivo expression of mammalian BiP ATPase mutants causes disruption of the endoplasmic reticulum. Mol Biol Cell (1995) 1.53

Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus. Virology (1987) 1.52

Receptor specificities of human respiroviruses. J Virol (2001) 1.48

Sendai virion transcriptase complex: polyeptide composition and inhibition by virion envelope proteins. J Virol (1974) 1.45

Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions. J Virol (1998) 1.43

A temperature-sensitive mutant of Sendai virus with an altered hemagglutinin-neuraminidase polypeptide: consequences for virus assembly and cytopathology. Virology (1975) 1.43

The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity. Virology (1990) 1.39

Complementary RNAs in paramyxovirions and paramyxovirus-infected cells. Nature (1970) 1.38

Isolation and characterization of Sendai virus temperature-sensitive mutants. J Virol (1974) 1.38

On the genesis of incomplete Sendai virions. Virology (1970) 1.35

Identification of transcriptive and replicative intermediates in Sendai virus-infected cells. Virology (1972) 1.34

Chromosome 1 contains the endogenous RAV-0 retrovirus sequences in chicken cells. Proc Natl Acad Sci U S A (1979) 1.32

Crystallization of Newcastle disease virus hemagglutinin-neuraminidase glycoprotein. Virology (2000) 1.29

Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one. Vaccine (1997) 1.28

The genome of frog virus 3, an animal DNA virus, is circularly permuted and terminally redundant. Proc Natl Acad Sci U S A (1982) 1.28

The fusion glycoprotein of Sendai virus: sequence analysis of an epitope involved in fusion and virus neutralization. Virology (1987) 1.28

An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein. Proc Natl Acad Sci U S A (1985) 1.26

The M2 ectodomain is important for its incorporation into influenza A virions. J Virol (1998) 1.25

Separate domains of Sendai virus P protein are required for binding to viral nucleocapsids. Virology (1990) 1.24

Antibodies against Sendai virus L protein: distribution of the protein in nucleocapsids revealed by immunoelectron microscopy. Virology (1988) 1.24

Localization and characterization of Sendai virus nonstructural C and C' proteins by antibodies against synthetic peptides. Virus Res (1986) 1.24

Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature-sensitive mutants. Virology (1987) 1.23

The HN glycoprotein of Sendai virus: analysis of site(s) involved in hemagglutinating and neuraminidase activities. Virology (1981) 1.21

Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines. J Virol (1990) 1.21

Structural and functional analysis of Sendai virus nucleocapsid protein NP with monoclonal antibodies. Virology (1984) 1.21

Mice lacking CD8+ T cells develop greater numbers of IgA-producing cells in response to a respiratory virus infection. Virology (1994) 1.17

Abortive replication of influenza virus A/WSN/33 in HeLa229 cells: defective viral entry and budding processes. Virology (1994) 1.16

Analysis of the primary T-cell response to Sendai virus infection in C57BL/6 mice: CD4+ T-cell recognition is directed predominantly to the hemagglutinin-neuraminidase glycoprotein. J Virol (1994) 1.15

Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood (1994) 1.14

Restriction of cell surface expression of Sendai virus hemagglutinin-neuraminidase glycoprotein correlates with its higher instability in persistently and standard plus defective interfering virus infected BHK-21 cells. Virology (1984) 1.13

Cloning and characterization of a second human CTP:phosphocholine cytidylyltransferase. J Biol Chem (1998) 1.13

Divergence between cytotoxic effector function and tumor necrosis factor alpha production for inflammatory CD4+ T cells from mice with Sendai virus pneumonia. J Virol (1993) 1.13

Localization of P, NP, and M proteins on Sendai virus nucleocapsid using immunogold labeling. Virology (1986) 1.11

A very sensitive biochemical assay for detecting and quantitating avian oncornaviruses. Virology (1977) 1.11

Regulatory events in the synthesis of Sendai virus polypeptides and their assembly into virions. Virology (1976) 1.11

A single sequence change destabilizes the influenza virus neuraminidase tetramer. Virology (1997) 1.10

A novel protein complex distinct from mismatch repair binds thioguanylated DNA. Mol Pharmacol (2001) 1.10

Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis. Am J Gastroenterol (1996) 1.10

Monoclonal antibodies to the P protein of Sendai virus define its structure and role in transcription. Virology (1985) 1.09

The nucleoproteins of human parainfluenza virus type 1 and Sendai virus share amino acid sequences and antigenic and structural determinants. J Gen Virol (1991) 1.09

Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT). Arch Otorhinolaryngol (1984) 1.08

Replication forms of the gene-sized DNA molecules of hypotrichous ciliates. Mol Cell Biol (1983) 1.08

Interaction of frog virus-3 with the cytoskeleton. I. Altered organization of microtubules, intermediate filaments, and microfilaments. J Cell Biol (1983) 1.07

Antibodies to paramyxovirus nucleoproteins define regions important for immunogenicity and nucleocapsid assembly. Virology (1993) 1.07

Functions of Sendai virus nucleocapsid polypeptides: enzymatic activities in nucleocapsids following cleavage of polypeptide P by Staphylococcus aureus protease V8. Virology (1981) 1.07

Assembly of vesicular stomatitis virus nucleocapsids in vivo: a kinetic analysis. J Virol (1979) 1.06

Homologous interference by incomplete Sendai virus particles: changes in virus-specific ribonucleic acid synthesis. J Virol (1971) 1.05

Sequence characterization and expression of the matrix protein gene of human parainfluenza virus type 1. Virology (1992) 1.05

Two noncontiguous regions of Sendai virus P protein combine to form a single nucleocapsid binding domain. Virology (1991) 1.05

Drastic immunoreactivity changes between the immature and mature forms of the Sendai virus HN and F0 glycoproteins. J Virol (1986) 1.04

The P genes of human parainfluenza virus type 1 clinical isolates are polycistronic and microheterogeneous. Virology (1992) 1.03

Human parainfluenza virus type 1 evolution combines cocirculation of strains and development of geographically restricted lineages. J Infect Dis (1994) 1.03

A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter (1998) 1.02

Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT). J Natl Cancer Inst (1985) 1.01

Measles virus ribonucleic acid and protein synthesis: effects of 6-azauridine and cycloheximide on viral replication. J Virol (1973) 1.01

Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med (1995) 1.01

Helical ribonucleoproteins of influenza virus: an electron microscopic analysis. Virology (1980) 1.00

The amino terminus targets the mixed lineage leukemia (MLL) protein to the nucleolus, nuclear matrix and mitotic chromosomal scaffolds. Leukemia (2000) 0.99

Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia. Blood (2000) 0.99

Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis. Blood (1999) 0.99

Mapping of antigenic domains of Sendai virus nucleocapsid protein expressed in Escherichia coli. J Virol (1988) 0.99

Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol (1998) 0.99

Charge heterogeneity in polypeptides of negative strand RNA viruses. Virology (1978) 0.99

Elevated expression of the human parainfluenza virus type 1 F gene downregulates HN expression. Virology (1997) 0.98